Target
CD274 (PD-L1)
6 abstracts
Abstract
Retrospective analysis on association of ABO blood type and immune checkpoint inhibitor response.Org: University of Vermont Medical Center, University of Vermont Department of Medicine, University of Vermont Biomedical Statistics, University of Vermont Medical Center, Dept of Pharmacy, University of Vermont Medical Center, Dept of Hematology Oncology,
Abstract
Using machine learning to characterize lung cancer microenvironment and the development of a model to predict the presence of similar microenvironment in other cancers.Org: Genomic Testing Cooperative, Irvine, CA, Genomics Testing Cooperative, John Theurer Cancer Center at Hackensack Meridian Health, HMH School of Medicine, Hackensack, NJ, Hackensack Meridian Health,
Abstract
Melanomas lacking HLA class I expression and response to checkpoint inhibitor.Org: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY,
Abstract
Efficacy and safety of first-line treatments for patients with advanced hepatocellular carcinoma: A systematic review and network meta-analysis.Org: The First Hospital of China Medical University, Shenyang, China, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, The First Affiliated Hospital of China Medical University,
Abstract
Stimulator of interferon gene (STING) expression as a biomarker for overall survival in PDL1-negative, TMB-low non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs).Org: Caris Life Sciences Research and Development, Caris Life Sciences, Irving, TX, Montefiore Einstein Center for Cancer Care, Lombardi Comprehensive Cancer Center, Georgetown University, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK,
Abstract
A study on oligo-progression after durvalumab plus platinum-etoposide for ES-SCLC.Org: Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan,